If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 receptor ...

礼来 (LLY.US)周四宣布，其胰岛素周制剂efsitora在QWINT-1和QWINT-3两项临床3期试验中达到了主要终点，表明这是一种对2型糖尿病成人患者来说更方便的治疗方案。

The phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better ...

The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

Eli Lilly product development senior vice-president Jeff Emmick said: “Once weekly insulins like efsitora have the potential ...

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

Health department officials said samples of Betamethasone sodium phosphate tablets, Nimesulide and Paracetamol tablets, Acebrophylline and Acetylcysteine tablets, Insulin Glargine injection, and ...

Eli Lilly's efsitora alfa was noninferior to once-daily insulin in type 2 diabetes, but an increased hypoglycemia risk was seen in type 1 diabetes.

Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...

A pair of late-stage trials found that Eli Lilly’s experimental once-weekly insulin can lower blood sugar as effectively as ...

周四美股成交额第1名英伟达收高0.94%，成交322.14亿美元。美银称，英伟达关键的基本面复苏催化剂可能是未来几周的供应链数据，确认Blackwell新芯片的出货准备就绪。美银的英伟达目标价意味着，预计股价将较本周三涨55%。 此外半导体制造商Xockets周四向美国得州西区地方法院提起诉讼，指控英伟达及其合作伙伴微软侵犯了七项涉及半导体技术的专利，这些技术可将与人工智能计算相关的数据密集型任务 ...